Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design
March 19, 2018
| By Mary Engel / Fred Hutch News Service
Fred Hutch structural biologist Dr. Marie Pancera is seeking clues for designing a malaria vaccine by studying the differences between newly discovered antibodies that bind the same site on the malaria parasite.
From lack of data to inconclusive blood tests to the unique challenges of pregnancy, experts weigh in on the knowledge gaps in this emerging infection
Feb. 2, 2016
| By Rachel Tompa / Fred Hutch News Service
The sudden appearance of Zika virus in the Americas — and the seemingly new tie to the birth defect where infants’ brains don’t full develop during pregnancy — underscore the huge gaps in our knowledge about the disease.
Vaccine potentially could be used in the majority of breast cancer patients
Dec. 3, 2014
| By Diane Mapes / Fred Hutch News Service
They may be baby steps, but researchers at Washington University School of Medicine in St. Louis took a few more of them this week with the publication of a study looking at a potential new breast cancer vaccine. Fred Hutch researchers weigh in and discuss their own breast cancer vaccine-related work.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.